Screener
Integra LifeSciences IART EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Integra LifeSciences’s reported figures.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
FAQ
- What is Integra LifeSciences's EBITDA?
- Integra LifeSciences (IART) reported EBITDA of $61.19M in Q2 2026.
- How has Integra LifeSciences's EBITDA changed year-over-year?
- Integra LifeSciences's EBITDA increased by 113.0% year-over-year, from -$471.23M to $61.19M.
- What is the long-term trend for Integra LifeSciences's EBITDA?
- Over 4 years (2021 to 2025), Integra LifeSciences's EBITDA has grown at a 1.2% compound annual growth rate (CAGR), from $333.98M to -$349.62M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Integra LifeSciences's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude